Serveur d'exploration sur la visibilité du Havre - Analysis (France)

Index « Auteurs » - entrée « Charles Zarnitsky »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Charles Zarnitski < Charles Zarnitsky < Charline Lasnon  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000002 (2016-07-07) Divi Cornec [France] ; Valérie Devauchelle-Pensec [France] ; Xavier Mariette [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Xavier Puéchal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Jacques-Eric Gottenberg [France] ; Laurent Chiche [France] ; Eric Hachulla [France] ; Pierre Yves Hatron [France] ; Vincent Goeb [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost [France] ; Philippe Saliou [France] ; Jacques Olivier Pers Dds [France] ; Raphaèle Seror [France] ; Alain Saraux [France]Severe Health-Related Quality-of-life Impairment in Active Primary Sjögren's Syndrome Is Driven by Patient-Reported Outcomes: Data from a Large Therapeutic Trial.
000046 (2016) Jacques-Eric Gottenberg [France] ; Olivier Brocq [Monaco] ; Aleth Perdriger [France] ; Slim Lassoued [France] ; Jean-Marie Berthelot [France] ; Daniel Wendling [France] ; Liana Euller-Ziegler [France] ; Martin Soubrier [France] ; Christophe Richez [France] ; Bruno Fautrel [France] ; Arnaud L. Constantin [France] ; Xavier Mariette [France] ; Jacques Morel [France] ; Melanie Gilson [France] ; Gregoire Cormier [France] ; Jean Hugues Salmon [France] ; Stephanie Rist [France] ; Frederic Lioté [France] ; Hubert Marotte [France] ; Christine Bonnet [France] ; Christian Marcelli ; Jeremie Sellam [France] ; Olivier Meyer [France] ; Elisabeth Solau-Gervais [France] ; Sandrine Guis [France] ; Jean-Marc Ziza [France] ; Charles Zarnitsky [France] ; Isabelle Chary-Valckenaere [France] ; Olivier Vittecoq [France] ; Alain Saraux [France] ; Yves-Marie Pers [France] ; Martine Gayraud [France] ; Gilles Bolla [France] ; Pascal Claudepierre [France] ; Marc Ardizzone [France] ; Emmanuelle Dernis [France] ; Maxime A. Breban [France] ; Olivier Fain [France] ; Jean-Charles Balblanc [France] ; Ouafaa Aberkane [France] ; Marion Vazel [France] ; Christelle Back [France] ; Sophie Candon [France] ; Lucienne Chatenoud [France] ; Elodie Perrodeau [France] ; Jean Sibilia [France] ; Philippe Ravaud [France]Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.
000107 (2015-08-31) Divi Cornec [France] ; Valérie Devauchelle-Pensec [France] ; Xavier Mariette [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Xavier Puéchal [France] ; Véronique Le Guern ; Jean Sibilia [France] ; Jacques-Eric Gottenberg [France] ; Laurent Chiche [France] ; Eric Hachulla [France] ; Pierre Yves Hatron [France] ; Vincent Goeb [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost ; Raphaèle Seror [France] ; Jacques-Olivier Pers [France] ; Petra M. Meiners ; Arjan Vissink [Pays-Bas] ; Hendrika Bootsma ; Emmanuel Nowak [France] ; Alain Saraux [France]Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
000145 (2015) Xavier Le Loët [France] ; Julia Nicolau [France] ; Patrick Boumier [France] ; Alain Daragon [France] ; Othmane Mejjad [France] ; Sophie Pouplin [France] ; Charles Zarnitsky [France] ; Olivier Vittecoq [France] ; Patrice Fardellone [France] ; Jean-François Ménard [France]Validation of the 2010-ACR/EULAR -classification criteria using newly EULAR-defined erosion for rheumatoid arthritis on the very early arthritis community-based (VErA) cohort.
000170 (2015) Michel Delforge [Belgique] ; Leonard Minuk [Canada] ; Jean-Claude Eisenmann [France] ; Bertrand Arnulf [France] ; Letizia Canepa [Italie] ; Alberto Fragasso [Italie] ; Serge Leyvraz [Suisse] ; Christian Langer [Allemagne] ; Yousef Ezaydi [Royaume-Uni] ; Dan T. Vogl [États-Unis] ; Pilar Giraldo-Castellano [Espagne] ; Sung-Soo Yoon [Corée du Sud] ; Charles Zarnitsky [France] ; Martine Escoffre-Barbe [France] ; Bernard Lemieux [Canada] ; Kevin Song [Canada] ; Nizar Jacques Bahlis [Canada] ; Shien Guo [États-Unis] ; Mara Silva Monzini [États-Unis] ; Annette Ervin-Haynes [États-Unis] ; Vanessa Houck [États-Unis] ; Thierry Facon [France]Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
000280 (2014-02-18) Valérie Devauchelle-Pensec [France] ; Xavier Mariette [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Xavier Puéchal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Jacques-Eric Gottenberg [France] ; Laurent Chiche [France] ; Eric Hachulla [France] ; Pierre Yves Hatron ; Vincent Goeb [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost ; Jacques-Olivier Pers [France] ; Emmanuel Nowak [France] ; Alain Saraux [France]Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
000329 (2014) Jacques-Eric Gottenberg [France] ; Philippe Ravaud [France] ; Xavier Puéchal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Vincent Goeb [France] ; Claire Larroche [France] ; Jean-Jacques Dubost [France] ; Stéphanie Rist [France] ; Alain Saraux [France] ; Valérie Devauchelle-Pensec [France] ; Jacques Morel [France] ; Gilles Hayem [France] ; Pierre Hatron [France] ; Aleth Perdriger [France] ; Damien Sene [France] ; Charles Zarnitsky [France] ; Djilali Batouche [France] ; Valérie Furlan [France] ; Joelle Benessiano [France] ; Elodie Perrodeau [France] ; Raphaele Seror [France] ; Xavier Mariette [France]Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
000453 (2013) Jacques-Eric Gottenberg [France] ; Gael Cinquetti [France] ; Claire Larroche [France] ; Bernard Combe [France] ; Eric Hachulla [France] ; Olivier Meyer [France] ; Edouard Pertuiset [France] ; Guy Kaplanski [France] ; Laurent Chiche [France] ; Jean-Marie Berthelot [France] ; Bruno Gombert [France] ; Philippe Goupille [France] ; Christian Marcelli [France] ; Séverine Feuillet [France] ; Jean Leone [France] ; Jean Sibilia [France] ; Charles Zarnitsky [France] ; Philippe Carli [France] ; Stephanie Rist [France] ; Philippe Gaudin [France] ; Carine Salliot [France] ; Muriel Piperno ; Adeline Deplas [France] ; Maxime Breban [France] ; Thierry Lequerre [France] ; Pascal Richette [France] ; Charles Ghiringhelli [France] ; Mohamed Hamidou [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
000517 (2012-06-06) Valérie Devauchelle-Pensec [France] ; Xavier Mariette [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Eric Hachulla [France] ; Xavier Puechal [France] ; Veronique Le Guern [France] ; Jean Sibilia [France] ; Jacques-Eric Gottenberg [France] ; Laurent Chiche [France] ; Vincent Goëb [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jj Dubost [France] ; Jacques-Olivier Pers [France] ; Emmanuel Nowak [France] ; Alain Saraux [France]Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Aged
3Female
3Humans
3Male
2Adult
2Aged, 80 and over
2Middle Aged
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Arthritis, Rheumatoid (classification)
1Arthritis, Rheumatoid (diagnosis)
1Cohort Studies
1Cross-Sectional Studies
1Dexamethasone (administration & dosage)
1Double-Blind Method
1Enzyme Inhibitors (therapeutic use)
1Fatigue (drug therapy)
1Fatigue (etiology)
1Health Status
1Hydroxychloroquine (therapeutic use)
1Melphalan (administration & dosage)
1Multiple Myeloma (diagnosis)
1Multiple Myeloma (drug therapy)
1Multiple Myeloma (psychology)
1Pain (drug therapy)
1Pain (etiology)
1Prednisone (administration & dosage)
1Quality of Life (psychology)
1ROC Curve
1Sjogren's Syndrome (complications)
1Sjogren's Syndrome (drug therapy)
1Synovitis (classification)
1Synovitis (diagnosis)
1Thalidomide (administration & dosage)
1Thalidomide (analogs & derivatives)
1Treatment Outcome
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Charles Zarnitsky" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Charles Zarnitsky" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Charles Zarnitsky
}}

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024